Table 4 The health expenditures of KardioPro
Strategies | All health expenditures | Cost components | ||||
|---|---|---|---|---|---|---|
Difference in total costs | Difference in hospital costs | Difference in physician costs | Difference in pharmaceutical costs | Difference in other* costs | ||
KardioPro for all risk groups | Difference in study population in millions € (SE) | 8.84 | −1.63 | 9.14 | −0.86 | 2.18 |
(1.75) | (1.25) | (0.29) | (0.88) | (0.70) | ||
Mean difference per pair in € (SE) | 674.35 | −124.67 | 697.08 | −65.51 | 253.13 | |
(134.42) | (96.20) | (21.68) | (66.68) | (53.74) | ||
KardioPro for the CHD group | Difference in study population in millions € (SE) | 0.67 | −0.33 | 1.7 | −0.41 | −0.28 |
(0.86) | (0.73) | (0.11) | (0.31) | (0.37) | ||
Mean difference per pair in € (SE) | 473.92 | −234.95 | 1,205.13 | −287.29 | 38.88 | |
(607.50) | (513.24) | (82.18) | (217.38) | (265.70) | ||
KardioPro for the high-risk group | Difference in study population in millions € (SE) | 0.58 | −0.74 | 0.97 | 0.13 | 0.22 |
(0.54) | (0.41) | (0.08) | (0.16) | (0.24) | ||
Mean difference per pair in € (SE) | 604.79 | −768.09 | 1,005.87 | 135.68 | 57.04 | |
(554.86) | (430.80) | (81.05) | (165.36) | (252.03) | ||
KardioPro for the medium-risk group | Difference in study population in millions € (SE) | 1.44 | −0.27 | 1.38 | −0.34 | 0.66 |
(0.73) | (0.54) | (0.09) | (0.33) | (0.25) | ||
Mean difference per pair in € (SE) | 832.47 | −153.44 | 799.42 | −199.39 | 799.42 | |
(424.84) | (305.99) | (55.84) | (194.26) | (55.84) | ||
KardioPro for the low-risk group | Difference in study population in millions € (SE) | 6.15 | −0.29 | 5.09 | −0.24 | 1.59 |
(1.21) | (0.75) | (0.23) | (0.74) | (0.48) | ||
Mean difference per pair in € (SE) | 682.84 | −33.01 | 564.81 | −26.60 | 564.81 | |
(137.43) | (86.76) | (25.14) | (80.98) | (25.14) |